3Dowell F J, Benessiano J, Poitevin P, et al. Effects of chronic losartan treatment on vascular reactivity in normotensive rats[J]. J Hypertens, 1997, 15(5):523-529.
4Bujan J, Bellon J M, Sabater C, et al. Modifications induced by atherogenic diet in the capacity of the arterial wall in rats to respond to surgical insult[J]. Atherosclerosis, 1996, 122 (2): 141-152.
5Christensen KI. Revision of Crataegus Sect. Crataegus and Nothosect. Crataeguineae (Rosaceae B Maloideae) in the Old World. Systematic Botany Monographs, 1992, 35: 1B199.
6Mabberley DJ. The plant-book: a portable dictionary of the vascular plants. Cambridge. UK: Cambridge University Press, 1997:858.
7Rigelsky JM, Sweet BV. Hawthorn: pharmacology and therapeutic uses. Am J Health Syst Pharm, 2002,59(5) : 417-422.
8Beier A, Konigstein RP, Samec V. Clinical experiences with a crataegus pentaerythrityl-tetranitrate combination drug in heart diseases due to coronary sclerosis in old age. Wien Med Wochenschr, 1974,124(24) :378-381.
9Taskov M. On the corona~ and cardiotonic action of crataemon. Acta Physiol Pharmacol Bulg, 1977,3 (4) : 53- 57.
10Ammon HP, Handel M. Crataegus, toxicology and pharmacology. Part Ⅱ: Pharmacodynamics. Planta Med, 1981, 43 ( 3 ) :209-239.
